Search Results

There are 113630 results for: content related to: A randomized study of screening for ovarian cancer: a multicenter study in Japan

  1. The use and understanding of CA125 as a tumor marker for ovarian cancer: a questionnaire-based survey

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 439–445, E.L. MOSS, J. HOLLINGWORTH, M. HOLLAND, D.J. MURPHY, I. FERNANDO and T.M. REYNOLDS

    Article first published online : 10 AUG 2007, DOI: 10.1111/j.1525-1438.2007.01043.x

  2. You have free access to this content
    Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors

    International Journal of Gynecological Cancer

    Volume 18, Issue 1, January/February 2008, Pages: 59–65, C.R. FERREIRA, J.P. CARVALHO, F.A. SOARES, S.A.C. SIQUEIRA and F.M. CARVALHO

    Article first published online : 19 MAY 2007, DOI: 10.1111/j.1525-1438.2007.00988.x

  3. The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 496–500, T.S. BARLOW, M. PRZYBYLSKI, J.M. SCHILDER, D.H. MOORE and K.Y. LOOK

    Article first published online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00573.x

  4. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma

    International Journal of Gynecological Cancer

    Volume 12, Issue 5, September 2002, Pages: 438–442, U. Saygili, S. Guclu, T. Uslu, O. Erten and E. Dogan

    Article first published online : 15 OCT 2002, DOI: 10.1046/j.1525-1438.2002.01171.x

  5. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 99–107, M. MURAKAMI, T. MIYAMOTO, T. IIDA, H. TSUKADA, M. WATANABE, M. SHIDA, H. MAEDA, S. NASU, S. YASUDA, M. YASUDA and M. IDE

    Article first published online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00471.x

  6. Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 4, July/August 2008, Pages: 621–628, A.H.M.M. ARITS, J.E.G.M. STOOT, A.A.M. BOTTERWECK, F.J.M.E. ROUMEN and A.C. VOOGD

    Article first published online : 14 SEP 2007, DOI: 10.1111/j.1525-1438.2007.01064.x

  7. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA125 level in women with a pelvic mass

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 92–98, A.S. MOUSAVI, S. BORNA and S. MOEINODDINI

    Article first published online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00469.x

  8. A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue 6, November 2005, Pages: 1023–1034, T.G. EHLEN, P.J. HOSKINS, D. MILLER, T.L. WHITESIDE, C.F. NICODEMUS, B.C. SCHULTES and K.D. SWENERTON

    Article first published online : 17 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00483.x

  9. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 470–475, G.S. LEISEROWITZ, C. LEBRILLA, S. MIYAMOTO, H.J. AN, H. DUONG, C. KIRMIZ, B. LI, H. LIU and K.S. LAM

    Article first published online : 26 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01028.x

  10. Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen

    International Journal of Gynecological Cancer

    Volume 18, Issue 5, September/October 2008, Pages: 996–1006, N. SUZUKI, Y. TAMADA, K. SHIGIRAHARA, A. SUZUKI, N. SUSUMU, I. ISHIDA and D. AOKI

    Article first published online : 20 NOV 2007, DOI: 10.1111/j.1525-1438.2007.01147.x

  11. What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?

    International Journal of Gynecological Cancer

    Volume 7, Issue 1, January 1997, Pages: 42–45, T. Beşe, F. Demi̇rkiran, M. Arvas, A.U. öz, D. Kösebay and E. Erkün

    Article first published online : 10 JUN 2003, DOI: 10.1046/j.1525-1438.1997.00422.x

  12. CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 13, Issue 2, March 2003, Pages: 120–124, S. Memarzadeh, S. B. Lee, J. S. Berek and R. Farias-Eisner

    Article first published online : 26 MAR 2003, DOI: 10.1046/j.1525-1438.2003.13019.x

  13. Treatment goals in ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue s1, May 2005, Pages: 3–11, R. F. Ozols

    Article first published online : 11 APR 2005, DOI: 10.1111/j.1525-1438.2005.15351.x

  14. Stage- and CA125–related survival in patients with epithelial ovarian cancer treated at a cancer center

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 18–24, R.E. BOARD, C.T.P.H. BRUIJNS, A.E. PRONK, W.D.J. RYDER, P.M. WILKINSON, R. WELCH, J.H. SHANKS, G. CONNOLLY, R.J. SLADE, K. REYNOLDS, H.C. KITCHENER and G.C. JAYSON

    Article first published online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00308.x

  15. Serial Changes of Serum CA125 Levels during Menstrual Cycles

    Asia-Oceania Journal of Obstetrics and Gynaecology

    Volume 17, Issue 4, December 1991, Pages: 369–378, Hirofumi Nonogaki, Shingo Fujii, Ikuo Konishi, Yoshihiko Nanbu, Fuminori Kobayashi and Takahide Mori

    Article first published online : 24 MAY 2010, DOI: 10.1111/j.1447-0756.1991.tb00288.x

  16. Serum CA125 assay at the time of relapse has no prognostic relevance in patients undergoing chemotherapy for recurrent ovarian cancer: a multicenter Italian study

    International Journal of Gynecological Cancer

    Volume 7, Issue 1, January 1997, Pages: 78–83, A. Gadducci, F. Landoni, T. Maggino, E. Sartori, P. Zola, M. Ferdeghini, G. Parma and R. Cristofani

    Article first published online : 10 JUN 2003, DOI: 10.1046/j.1525-1438.1997.00424.x

  17. Differential diagnosis of pelvic masses: Usefulness of CA125, transvaginal sonography and echo-Doppler

    International Journal of Gynecological Cancer

    Volume 8, Issue 4, July 1998, Pages: 315–321, Kusnetzoff, Gnochi, Damonte, Sananes, Giaroli, Di Paola and Sardi

    Article first published online : 5 JAN 2002, DOI: 10.1046/j.1525-1438.1998.97107.x

  18. Elevated CA125 level associated with Meigs’ syndrome: case report and review of the literature

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 315–318, A. MORÁN-MENDOZA, G. ALVARADO-LUNA, G. CALDERILLO-RUIZ, A. SERRANO-OLVERA, C.M. LÓPEZ-GRANIEL and D. GALLARDO-RINCÓN

    Article first published online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00228.x

  19. Tumor tissue CA125 in ovarian carcinoma patients with normal serum levels

    International Journal of Gynecological Cancer

    Volume 7, Issue 4, July 1997, Pages: 304–306, J. MENCZER, H. ZAKUT, E. SCHEJTER, S. GINATH, L. TELL and L. ZAJDEL

    Article first published online : 11 JUN 2003, DOI: 10.1046/j.1525-1438.1997.00459.x

  20. Struma ovarii showing clinical characteristics of ovarian malignancy

    International Journal of Gynecological Cancer

    Volume 15, Issue 6, November 2005, Pages: 1156–1159, S.Y. RIM, S.M. KIM and H.S. CHOI

    Article first published online : 17 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00328.x